Physician profile
Paul A Hansen
NPI 1023218906
$5,178.56
in general payments reported to CMS, 2019-2025
13 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $501 · 2021: $547 · 2022: $1,291 · 2023: $726 · 2024: $869 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,310.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,330.60 | 2019-2025 | Penumbra System, Red 72, Pod |
| Stryker Corporation | $423.24 | 2019-2025 | Evolve |
| Route 92 Medical, INC. | $398.48 | 2021-2022 | |
| Imperative Care, INC | $322.73 | 2023-2025 | Zoom 88-T Large Distal Platform |
| Medtronic, INC. | $208.91 | 2024-2025 | Pipeline |
| Medical Device Business Services, INC. | $130.20 | 2023 | |
| Depuy Synthes Sales INC. | $90.63 | 2022-2023 | Emboguard |
| Microvention, INC. | $86.33 | 2020 | |
| Qapel Medical INC | $44.80 | 2024 | |
| Merz Pharmaceuticals, LLC | $42.86 | 2022 | |
| Phenox INC. | $42.23 | 2022 | |
| Cordis US Corp. | $36.33 | 2024 | Precise Pro Rx |
| Astrazeneca Pharmaceuticals LP | $21.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.